Upcoming webinars
Sign up for our upcoming webinars below!
Multiomics from a single blood sample: combining Nightingale metabolomics with NULISA proteomics to brain health research and beyond
November 25, 2025
3 p.m. CET
Join the webinar to explore Nightingale Health’s latest addition to our multiomics portfolio for medical research: proteomic biomarkers from Alamar’s NULISA CNS and Inflammation Panels.
Nightingale now offers the leading targeted metabolomics and proteomics platforms as a combined service for population health research. The long-standing value of our metabolomics platform across the disease spectrum is hereby complemented by ultra-sensitive biomarkers captured by Alamar’s NULISA proteomics assay. This provides unprecedented opportunities to study how systemic metabolism and vascular health relate to neurodegenerative diseases such as dementia.
The webinar will be run jointly by experts from Nightingale and Alamar. Learn how proteomics with attomolar sensitivity can detect the hottest blood biomarkers in neurology, such as brain-derived pTau, and understand how this opens possibilities for dissecting the relation between the health of heart and brain.
Multiomic insights into human disease
December 3, 2025
3 p.m. CET
Join us for an exploration of how integrating proteomics and metabolomics can deepen our understanding of human health and disease. Our Principal Scientist Dr. Luke Jostins-Dean will present new analyses from the UK Biobank, where both proteomic and metabolomic data are now available for 50,000 individuals—with plans to scale to all 500,000 participants. By examining the complementarities between these two molecular layers, we’ll demonstrate how multiomic data can uncover new biological insights.
New study demonstrates the cost-effectiveness of metabolomics-based health checks
December 4, 2025
3 p.m. CET
Professor Janne Martikainen has over two decades of experience in health economics and outcomes research (HEOR). He has served as both principal and co-investigator on numerous research projects, focusing on the health economic aspects and outcomes of interventions for preventing and treating cardiometabolic diseases and memory disorders.